FI78237B - MEDEL FOER BEHANDLING AV SAOR. - Google Patents

Description

1 78237

Wound preparation

Preparations for the treatment of wound inflammation are known. In addition to the usual textile ties 5, e.g. a dextran-based product for wound healing (U.S. Patent 4,225,580).

However, the disadvantage of this material is its relatively difficult applicability and, in particular, the difficulty of removing it from the wound, since small dextran particles easily adhere to the edges of the wound.

It has now been found that a wound preparation containing 2-20% by weight of a graft copolymer consisting of starch and hydrolyzed polyacrylonitrile in which 5-90% of the hydrogen atoms of the carboxyl groups have been replaced by aluminum-15 suspended in a physiologically acceptable lipophilic containing 1-3 surfactants or the paste has substantially more advantageous properties than previously known preparations for the same use.

The graft copolymer of starch and hydrolyzed polyacrylonitrile in which 5-90% of the hydrogen atoms of the carboxyl groups have been replaced by aluminum for use in the preparation of the invention can be prepared, for example, as described in U.S. Pat. No. 4,302,369 such as in the presence of cerium ammonium nitrate, hydrolyzing the resulting graft copolymer with a strong base and then reacting it with aluminum salts. The product obtained can be dried, washed with an alcoholic solution of ammonia and adjusted to pH 6.0-7.5 with hydrochloric acid. On the other hand, however, it is also possible to obtain this product, for example, from Henkel Corporation, Minneapolis, 35 which supplies it under the trade name SGP 157 M.

2,78237

Graft copolymers suitable for the production of the preparations according to the invention have the following properties: the ratio of the starch component to the acrylate and acrylamide component is preferably 1: 3 to 1: 0.9, the ratio of carboxyl groups to amide groups is preferably 2: 1 to 9: 1, and in the polymer is preferably 25-75% of the carboxyl groups substituted by aluminum.

As lipophilic liquids, hydrocarbons such as, for example, paraffin or petrolatum, stearin-10 can be used, as well as vegetable and animal oils, waxes or fats, such as, for example, jojoba oil, olive oil, peanut oil, coconut oil, coconut oil, almond oil, sunflower oil, sunflower oil. beeswax, wool grease, etc.

Both nonionic and ionic surfactants are suitable for use as physiologically acceptable surfactants. Non-ionic surfactants may be mentioned lecithin, lesitiinifraktiot and other conversion products, polyoxyethylene leenirasvahappoesterit, polyoxyethylene fatty alcohol 20 ethers, polyoxyethylated sorbitan fatty acid esters, glycerol polyethyleneglycol oxystearate, glyserolipo-lyetyleeniglykolirisinoleaatti, ethoxylated soijaste-porphyrins, ethoxylated castor oils and the hydrogenated derivatives thereof, cholesterol, polyoksietyleenipolyoksipropy-25 lene polymers, of which polyoxyethylene-polyoxypropylene polymers having a molecular weight of 6800-8975 are preferred, e.g. Pluronic 'F 68.

Particularly preferred surfactants for use in the preparations according to the invention are listed in claims 3-5.

Suitable surfactants containing polyethylene groups for the preparation of the preparations according to the invention are, for example, polyethylene glycols having a molecular weight of more than about 1000, sparingly water-soluble polypropylene niglycols and block polymers of both compounds, (commercially available from Pluronic). 7 F 68 used in the preparation according to the invention up to 5% by weight, based on the weight of the whole preparation.

3,78237

Other surfactants containing polyethylene groups suitable for the preparation of the preparations according to the invention are exemplified by the trade names Cremophor®.

El sold products.

5 Fatty alcohol sulphates are also quite suitable for use as surfactants, eg under the trade names (R)

Products sold by Lanette E or N.

Examples of fatty alcohols or cholestrol-containing surfactants suitable for the preparation of the preparations according to the invention are stearyl alcohol, palmityl alcohol, mixtures thereof, for example the product sold under the trade name Lanette, or cholesterol contained in lanolinine.

Since the suitability of a surfactant depends solely on its properties and not on its chemical structure, mixtures of several surfactants are as suitable for use as a single surfactant. In addition to surfactants, the preparation according to the invention further contains lipophilic liquids or pastes, preferably consisting of the 20 components mentioned in claims 6 and 7.

High-boiling paraffins suitable for use in the preparation of the invention include liquid, viscous, waxy or solid paraffins commonly used in galenic products, e.g. those (R) available as commercial products under the name Vaseline. Also suitable substances are paraffins emulsified with wool fatty alcohols, for example the products sold under the trade name Eucerin '1.

Suitable components for the product according to the invention are, for example, vegetable or animal oils, waxes or fats, which have already been mentioned above.

From the individual components used in addition to the graft copolymer in the preparation according to the invention, mixtures are prepared under known conditions used in the preparation of galenic products, the properties of which are determined by the desired field of application of the preparation according to the invention.

4,78237

To prepare the product, the components are mixed, e.g. in a suitable mill, into a uniform mixture and heat-sterilized.

The wound treatment preparation according to the invention is suitable not only in the narrower sense for the treatment of wounds but also for the treatment of numerous inflammations or lesions of the skin or mucous membranes in which fluid is excreted, e.g. 10 in "Rote Liste - 1980" are listed in connection with wound dressings. Such cases of illness and damage include, for example, surgical wounds, puncture wounds, tear-wound wounds, compression wounds, burn wounds, frostbite wounds, scratches, sunburn, rashes, hemorrhoids, and the like.

The wound treatment preparation according to the invention may further contain additives and auxiliaries (e.g. perfumes) customarily used in such preparations, as well as further active substances which are usually added to such preparations. Examples of active ingredients are bacteriostatic agents, antifungals and local anesthetics. As bacteriostatic agents, sulfonamides such as sulfacine or sulfatolamide can be used, or antibiotics such as penicillins, etc. As antimycotics, salicylic acid or its derivatives such as salicylhydroxamic acid ester and salicylamide ester such as miconazole, isoconazole, etc. can be used. ethyl ester, etc.

30 The product is applied to the area to be treated and possibly covered with gauze.

The preparation according to the invention is characterized by a very good absorbency, due to which it causes a rapid healing when removing water from the wound.

The lipophilic components and surfactants contained in the preparation according to the invention have a vapor pressure lowering effect, so that the preparations according to the invention do not dry out. This avoids sticking to the wounds and the edges of the wound, so that the preparation can again be removed without difficulty. In addition, due to these components, the preparation is pasty and thus easy to apply.

The following embodiments further illustrate the preparations of the invention.

Example 1 2 g of graft copolymer SGP 157 M from Henkel (R)

Corporation, Minneapolis), 0.8 g of Pluronic 'F 68 and 10 g of Pur-oba oil are ground in one ball mill for 30 minutes to give a homogeneous dispersion.

Example 2 2 g of graft copolymer SGP 157 M (from Henkel Corporation, Minneapolis) is ground in a ball mill for 5 minutes with thin paraffin oil (1 g). 3 g of paraffin are then added and ground for 5 minutes, a further 6 g of paraffin and 1 g of Pluronic * F 68 are added to (R) 15 and ground for a further 20 minutes until a homogeneous dispersion is obtained.

Example 3 2 g of graft copolymer SGP 157 M (from Henkel 20 Corporation, Minneapolis) with a grain size of less than 0.063 mm (R) and 5 g of Pluronic '' F 68 with a grain size of less than 0.075 mm are ground with a thin paraffin oil (20 g) with. 50 g of white petrolatum and 25 g of thick paraffin oil are then added to the mixture, and the mixture is triturated until a homogeneous homogeneous dispersion is obtained.

Example 4 2 g of graft copolymer SGP 157 M from Henkel (R)

Corporation, Minneapolis) and 10 g of Cremophor El are rubbed together. 90 g of white petrolatum are added portionwise to the mixture and the mixture is triturated until a homogeneous dispersion is obtained.

Example 5 2 g of graft copolymer SGP 157 M (from Henkel Corporation, Minneapolis) are triturated with Cremophor '35 E1 (10 g) and polyethylene glycol (molecular weight 400) (10 g). 80 g of white copper line are then added and the mixture is triturated until a homogeneous dispersion is obtained.

Example 6 2 g of graft copolymer SGP 157 M (from Henkel 5 Corporation, Minneapolis) with a grain size of less than 0.063 mm (R 1 and 0.8 g of Pluronic 7 F 68 with a grain size of less than 0.075 mm, (R) are ground with Cremophor 1 E1 (6 g) 36 g of white petrolatum are then added portionwise to the mixture and the mixture is triturated until a homogeneous dispersion is obtained Example 7 2 g of graft copolymer SGP 157 M (from Henkel)

Corporation, Minneapolis) with a grain size of less than 0.036 mm (R) and 0.8 g of Pluronic 7 F 68 with a grain size of less than 0.075 mm are ground with Cremophor E1 (4 g) and polyethylene glycol-15 Koli (molecular weight 400). (4 g). 4.8 g of white petrolatum are then added portionwise and the mixture is triturated until a homogeneous dispersion is obtained.

Example 8 2 g of graft copolymer SGP 157 M (from Henkel 20 Corporation, Minneapolis) with a grain size of less than 0.063 mm and 0.8 g of PluronicF 68 with a grain size of less than 0.075 mm (R) are triturated with Eucerin J (anhydrous, 20 g) to a homogeneous dispersion.

Example 9 2 g of graft copolymer SGP 157 M (from Henkel

Corporation, Minneapolis) with a grain size of less than 0.063 mm and 0.8 g of Pluronic 'J F 68 with a grain size of less than 0.75 mm are triturated with Cremophor E1 (4 g). 16 g of Eucerin '' Anhydr. 'Are then added portionwise (R) and the mixture is triturated to a uniform dispersion.

Example 10 2 g of graft copolymer SGP 157 M (from Henkel Corporation, Minneapolis) with a grain size of less than 0.063 mm (R 1 and 0.8 g of Pluronic 1 F 68 with a grain size of less than 0.075 mm) are triturated with a Cremophor. n (4 g) and polyethylene glycol (molecular weight 400) (4 g) Then add 7 78237 (p) in portions to 4.8 g of Eucerin Anhydr. and triturate until a homogeneous dispersion is obtained.

Example 11 2 g of graft copolymer SGP 157 M (from Henkel 5 Corporation, Minneapolis) having a grain size of less than 0.063 mm) (R1 and 0.8 g of Pluronic F 68 are ground with a base cream (20 g) to a uniform dispersion.

The base cream used is prepared as follows: 35 g of thick paraffin oil, 35 g of white petrolatum and 30 g of 10 Lanette® N are melted at 90 ° C and the mixture is stirred until cooled.

Example 12 2 g of graft copolymer SGP 157 M (from Henkel

Corporation, Minneapolis) with a grain size of less than 0.063 mm, (R) 15 and 0.8 g of Pluronic F 68 are mixed with a base cream (20 g) to a uniform dispersion.

The base cream used is prepared as follows: 6.0 g of (R) wool wax, 0.5 g of Lanette '0, 10.0 g of thick paraffin oil and 83.5 g of white petrolatum are melted at 90 ° C and the mixture is stirred until it is cool.

Example 13 2 g of graft copolymer SGP 147 M (from Henkel

Corporation, Minneapolis) with a grain size of less than 0.063 mm (R) is triturated with Pluronic F 68 (0.8 g) with a grain size (R) of less than 0.075 mm and Cremophor El (4 g). ).

16 g of the base cream prepared according to Example 11 are then added to the mixture, and the mixture is triturated to a homogeneous dispersion.

Example 14 As in Example 13, a homogeneous dispersion is prepared using, however, the base cream prepared in Example 12.

Claims (7)

8,78237 A preparation useful in the treatment of wounds containing a graft copolymer consisting of starch and hydroxylated polyacrylonitrile in which 5 to 90% of the hydrogen atoms of the carboxyl groups have been replaced by aluminum, characterized in that the preparation contains 2 to 20% by weight of said graft copolymer an acceptable lipophilic liquid or paste containing 1-3 surfactants. Preparation according to Claim 1, characterized in that it contains up to 5% by weight of surfactant in a physiologically acceptable lipophilic liquid. Preparation according to Claim 1 or 2, characterized in that it contains, as one component, a surfactant containing polyethylene groups. Preparation according to Claim 1 or 2, characterized in that it contains, as one component, a fatty alcohol sulphate as surfactant. Preparation according to Claim 1 or 2, characterized in that it contains, as one component, a fatty alcohol or cholesterol as a surfactant. Preparation according to one of Claims 1 to 5, characterized in that it contains high-boiling paraffin as one component. Preparation according to one of Claims 1 to 5, characterized in that it contains, as one component, vegetable or animal oil, wax or fat.